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Major histocompatibility complex (MHC)l-restricted T-cell-mediated cytotox- 
icity has  been demonstrated  for virus-infected  (1-5)  and  chemically modified 
(6-10)  murine  cells,  as  well  as  for  cells  expressing  weak  transplantation 
antigens  (11,  12). In each of these examples, the restriction was shown to map 
to the K  and/or D  regions of the H-2 complex. To investigate the immunogenic 
parameters  involved  in  the  sensitization  of cytotoxic effector cells,  it  was  of 
interest to study whether or not cytotoxic responses could be generated against 
soluble antigens  or antigenic  components which are not covalently linked  to 
cell surface products,  and if they could,  whether or not products of the  MHC 
would play a role in such sensitization.  Related to this issue is the observation 
that  inactivated  Sendai  virus,  which cannot  infect cells,  was associated with 
the  cell  surface  resulting  in the  generation  of H-2-restricted,  Sendai-specific 
cytotoxic effector cells  (13).  Recently,  it was shown that  cells whose surfaces 
are modified with an amphipathic  2,4,6-trinitrophenyl  (TNP) compound, TNP- 
stearyl-dextran  (TSD),  which  is  not  covalently  associated  with  cell  surface 
components,  are .neither  effective stimulators  for the  generation  of cytotoxic 
effector cells,  nor  efficient targets  for lysis by H-2-restricted,  trinitrobenzene 
sulfonate (TNBS)-specific cytotoxic lymphocytes (14).  The present report dem- 
onstrates that the addition of TNBS-conjugated soluble proteins such as bovine 
gamma globulin (TNP-BGG) or bovine serum albumin  (TNP-BSA) to cultures 
of mouse spleen  cells leads to the generation  of cytotoxic effector cells which 
are  both H-2-restricted  and  TNP-specific.  A  number  of variables  associated 
with this response were investigated. 
Materials  and  Methods 
Mice.  The C57BL/10 congeneic resistant lines, as well as the C3H.OH strains of mice used 
were purchased from The Jackson Laboratory, Bar Harbor, Maine. The A.TL, A.TH, A.AL, and 
B10.A(4R)  strains  were  provided by  Dr.  David Sachs,  Immunology Branch,  National  Cancer 
Institute. 
1  Abbreviations  used in this paper:  ADCC, antibody-dependent cellular cytotoxicity; AGG, ~- 
alanylglycylglycyl; BGG,  bovine gamma globulin; BSA, bovine serum albumin; HBSS, Hanks' 
balanced  salt  solution;  FBS,  fetal  bovine  serum;  KLH,  keyhole  limpet  hemocyanin;  LPS, 
lipepolysaccharide; MHC,  major histocompatibility complex;  NRS,  normal rabbit serum;  PBS, 
phosphate-buffered saline; RAMB, rabbit anti-mouse brain serum; SDS, sodium dodecyl  sulfate; 
TNBS, trinitrobenzene sulfonate; TNP, 2,4,6-trinitrophenyl; TSD, TNP-stearyl dextran. 
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Cell Cultures.  Mouse spleen cells (7  x  10  e) were cultured with either 3 x  10  e irradiated (2,000 
R)  stimulating cells  or with  soluble protein  antigens  at  100  ~g/ml final concentration unless 
otherwise  indicated,  in  RPMI  1640  tissue  culture  media  (Grand Island Biological  Co.,  Grand 
Island,  N.  Y.)  supplemented  with  10%  fetal bovine serum  (FBS)  (Microbiological Associates, 
Bethesda,  Md.),  5  x  10  -s  M  2-mercaptoethanol,  sodium  pyruvate,  nonessential  amino  acids, 
glutamine,  penicillin,  and  streptomycin,  in  a  2-ml  volume  in  24-well  culture  plates  (Linbro 
Chemical Co.,  New  Haven,  Conn.) at 37°C  in a  humidified incubator (3% CO2,  97% air).  TNP 
modification of stimulating cells was performed as previously described (6) using 10 mM TNBS 
(Pierce Chemical Co., Rockford, Ill.) unless otherwise stated. 
The mouse spleen cells were harvested after 5 days of culture unless otherwise indicated and 
tested  in  a  4-h 5~Cr release  assay  (7).  Cells  suspended  in Eagle's  minimal essential  medium 
containing  10%  FBS  were  assayed  at  various  effector:target  cell  ratios  in  round-bottomed 
microtiter plates (Cooke Laboratory Products Div. Dynatech Laboratories Inc., Alexandria, Va.) 
in  a  final  volume  of 200  ~1.  The target  cells  used  were  either RDM-4  (tl-2  k)  or EL-4  (H-2 b) 
lymphoid tumors carried in ascites form, or 48-h cultures of mouse spleen cells incubated with a 
20-~g/ml final concentration of Escherichia  call 055:B5 lipopolysaccharide (LPS) (Difco Laborato- 
ries,  Detroit,  Mich.).  The target cells were labeled by incubation at 37°C for 1 h  with Na51CrO4 
(New  England  Nuclear,  Boston,  Mass.,  0.2  ~Ci/2  ×  107 cells).  The targets were  washed  and 
modified by incubation with  10  mM  TNBS at  37°C  for 10  min.  Excess TNBS  was removed by 
washing the modified,  labeled targets with Hanks' balanced salt solutions (HBSS)  containing 
10% FBS. 
After the effector and target cells had been incubated for 4 h  at 37°C in a  CO2 incubator, the 
microtiter plates were centrifuged and 100  /zl of the supernate was removed and counted in a 
gamma spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). The percent of specific 
lysis was calculated as described elsewhere (6). 
Stimulating and target cells were also prepared by incubating spleen and RDM-4 tumor cells 
respectively with the soluble protein antigens at 37°C (100/zg/ml final concentration) for various 
periods  of time  followed by two  or  three  washes  of the  cells with  HBSS-FBS.  These  washed 
spleen and tumor cells were then tested for their ability to serve as stimulating and target cells, 
respectively. 
Preparation  of TNP Proteins.  Proteins (BGG, serum fraction II and BSA, fraction V; Miles 
Laboratories Inc., Miles Research Products, Elkhart, Ind.) were dissolved in 0.4 M borate buffer 
pH 9.0,  at a  final concentration of 10 mg/ml of the reactive mixture, and TNBS was added to a 
final concentration of 20 mM and the mixture was incubated at 37°C overnight. These preparations 
were dialyzed sequentially against phosphate-buffered saline (PBS) pH 7.4, against PBS contain- 
ing  5  mM  glycylglycine,  and  twice  more  against  PBS  containing  AGlx8  beads  (Bio-Rad 
Laboratories,  Richmond,  Calif.)  at 4°C.  Calculations of TNP derivatization were based on the 
value of 15  ×  103 as molar extinction coefficient of TNP at 350 nm (15).  Batches of TNPzs_~o-BGG 
and TNP27-~5-BSA were used in these studies. 
lmrnunofluorescence.  All surface  staining with anti-TNP was done as previously described 
(14) with rhodamine-conjugated F(ab')2 fragments of the IgG fraction of affinity chromatography- 
purified sheep anti-TNP-keyhole limpet hemocyanin (KLH) antibodies. 
Treatment of  Effeetor Cells with Rabbit Anti-Mouse Brain Serum.  Effector cells from B10.BR 
donors  (107 cells/0.1  ml  media)  were  incubated for  30  rain  at  room  temperature  with  a  1:20 
dilution  of rabbit  anti-mouse  brain  serum  (RAMB,  a  gift  from  Dr.  R.  Hodes,  Immunology 
Branch,  National  Cancer  Institute)  which  had been absorbed  with  mouse  erythrocytes.  This 
RAMB has been shown to be specific for T  cells (16).  The effector cells were then washed and 
incubated with a  1:5 dilution of guinea pig complement (Grand Island Biological Co.) for 30 min 
at 37°C.  The effector cells were washed three times and tested in the 51Cr release assay. 
Cell Separations.  Ascites tumor cells were passed through columns of Sephadex G-10 (Phar- 
macia Fine Chemicals,  Inc.,  Piscataway,  N.  J.),  prepared as described by Ly and Mishell (17). 
2.1  ml of RDM-4 aecites tumor cells at a  concentration of 70  ×  10e/ml in HBSS containing 1% 
penicillin streptomycin and 5% FBS was passed through a 40-ml column of Sephadex G-10 and 40 
ml  of the  eluted  volume  was  collected.  Approximately  47% of the cells  was  recovered  in  the 
effluent.  Latex uptake was used for the detection of phagocytic cells as follows.  2-ml samples (3 
× 105 cells)  were incubated overnight in a roller  drum at 37°C with i0 ftl  of  latex particles (18)  in 
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acid buffer  (Microbiological  Associates,  Bethesda, Md.),  washed three times with cold  HBSS- 
FBS, centrifuged  at  700 rpm for  5 rain,  and counted. 
Radioiodination of  Spleen Cells.  B10.A spleen cells  were either  reacted in the presence of  1 
mM  TNBS for  10 min at  37°C,  washed twice with HBSS and once  with PBS, pH 7.4,  or  they  were 
incubated for  2 h at  37°C in culture  medium supplemented with 100 ~g/ml of  TNP-BSA, washed 
twice with HBSS-FBS  and once with PBS.  Lactoperoxidase-catalyzed iodination of surface 
proteins  was carried  out by a modification  of  the procedure of  Vitetta  et  al. (19).  Briefly,  2 mCi of 
12~I-Na,  1.6  mg of  lactoperoxidase  (Sigma Chemical Co.,  St. Louis,  Mo.),  and 40 ~l of  0.03% HsO2 
were added to 4 × 10  s  cells  in 4 ml PBS, followed  by an additional  20 ~l of  H202 after  a 10-rain 
incubation at room temperature. The reaction was stopped after  15 rain  by the addition of a 
quenching solution  composed of  PBS pH 7.4  containing 0.01  M  KI and 0.01  M  cysteine.  The cells 
were washed three  times in  the quenching  solution  and lysed  in 4 ml of  0.01  M  Tris,  pH 7.4,  0.15 
M  NaCl, containing 0.5% Nonidet P-40 (Particle  Data, Inc.,  Elmhurst, Ill.)  for  30 rain  on ice.  The 
cell  lysates  were centrifuged  at 100,000  g for  60 rain  at 4°C. 
Preparation and Analysis of Immune Precipitates.  0.1-ml samples of the lysates were incu- 
bated overnight on ice in the presence of 25  ~l of either normal rabbit serum, rabbit anti-TNP- 
KLH  serum  prepared as previously described (14),  rabbit anti-BSA (Miles-Yeda  Laboratories, 
Rehovot,  Israel)  or  mouse  anti-H-2  serum  (A.BY  anti-A)  provided by  Dr.  David  Sachs.  The 
immunoprecipitates were  obtained by the addition of Staphylococcus aureus  (Cowan  I)  strain 
bacteria  (10%  suspension of formalinized bacteria;  375  ~1 for rabbit serum,  250  ~l for mouse 
serum)  as  described by  Cullen and Schwartz  (20).  After 30  rain on  ice,  the  precipitates  were 
washed three times and eluted from the Cowan by boiling for 1 min in 0.4 ml of 0.06 M Tris, pH 
6.8,  2% sodium dodecyl sulfate (SDS), and 0.28 M 2-mercapthoethanol. After centrifugation, the 
supernates were subjected  to electrophoresis  for 3 h on 10-cm polyacrylamide gels  at 6 mA/gel 
(21).  Gels  were sliced,  counted  in  a gamma counter,  and the fraction  numbers were adjusted  from 
gel  to  gel  for  the migration  of  the phenol red dye. 
Results 
Generation of H-2-Restricted Cytotoxic  Effector Cells by TNP-BGG.  Spleen 
cells  from  B10.BR  (H-2  k)  donors  were  sensitized  in  vitro  for  5  days  by the 
addition of unmodified or TNBS-modified syngeneic spleen cells, BGG, or TNP- 
BGG and BSA, or TNP-BSA. In experiment  1,  the effector cells were assayed 
on unmodified RDM-4 (H-2 k) and EL-4 (H-2 b) tumor target cells and on TNBS- 
modified RDM-4 and EL-4 at the effector:target cell ratios shown (Table I). The 
results  indicate  that  the  addition  of TNP-BGG  to  the  cultures  led  to  the 
generation  of effector cells which were at least as efficient in lysing RDM-4- 
TNBS target  cells as were effectors generated  by sensitization  with  B10.BR- 
TNBS-stimulating cells. The effectors generated by addition of TNP-BGG were 
=  64-fold  more  efficient  in  lysing  the  H-2-matched,  TNBS-modified  RDM-4 
targets  than  were the non-H-2-matched,  modified EL-4 targets  in the experi- 
ment shown. The 64-fold greater efficiency of lysis was estimated by comparing 
the  effector:target  cell  ratios  required  to  give  equivalent  lysis  on  modified 
RDM-4  and  EL-4  targets;  i.e.,  0.625:1  for  20.3%  on  RDM-4-TNBS  compared 
with 40:1 for 17.2% on EL°4-TNBS (line 4 of Table I). A  similar estimation for 
effectors generated by sensitization with B10.BR-TNBS also indicated a  64-fold 
preferential lysis of RDM-4-TNBS compared with EL-4-TNBS. In other experi- 
ments using the same targets these effectors as well as the effectors generated 
by sensitization  with TNBS-modified syngeneic spleen cells or by the addition 
of TNP-BSA lysed TNBS-modified, H-2-matched tumor targets from 16- (exper- 
iment 2) to 64-fold better than modified non-H-2-matched tumor targets.  These 
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TABLE  I 
Generation of H-2-Restricted Effector Cells by the Addition of TNBS-Modified Syngeneic 
Cells or Soluble  TNP-BGG or TNP-BSA to Cultures of BIO.BR  Spleen Cells 
Percent specific ]ysis ±  standard error assayed on targets 
B10.BR Spleen 
cells sensitized by  RDM4  RDM4-TNBS  EL-4  EL-4-TNBS 
the addition of: 
40:1  40:1  i0:I  2.5:1  0.625:1  40:1  40:1  i0:i  2.5:1 
Experiment  1 
BI0.BR  [13.3]  -  [17.8]  [5.1]  [1.4]  [5.9]  [5.5]  [3.3]  [-0.5] 
B10.BR-TNBS  -6.6  ±  0.7  -  44.2  ±  3.1  34.1  ±  4.0  10.5  ±  2.3  1.0 ±  1.9  13.5  ±  3.3  1.6  ±  2.8  0.8  ±  2.5 
BGG  [17.7]  -  [21.5]  [6.1]  [0.7]  [7.6]  [12.7]  [3.4]  [0.4] 
TNP-BGG  3.2  -+  1.9  -  45.3  ±  6.1  40.6  ±  2.3  20.3  ±  2.1  9.7  ±  2.5  17.2  ±  5.8  11.6  ±  3.0  5.0  ±  1.0 
Experiment 2 
BSA  [25.1]  [15.3]  [6.2]  -  [8.8]  [2.8]  [0.2] 
TNP-BSA  -  28.7  ±  3.7  27.3  ±  1.9  9.8 ±  1.9  -  9.1  ±  0.5  3.8 ±  1.0  2.5  ±  1.3 
Values in brackets indicate the lysis above media controls by spleen cells cultured for 5 days in the presence of B10.BR or BGG without 
TNP, and serve as the controls for the respective specific responses generated by addition  of B10.BR-TNBS or TNP-BGG. The percent 
specific lysis was calculated  by subtracting the values in brackets from the total lye[s, e.g., 44.2  =  62.0  -  17.8.  All specific lysis data 
shown in subsequent tables were calculated in this way. 
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Fro.  1.  Percent  lysis  by  B10.BR  effector  cells  after  addition  of  different  numbers  of 
unmodified  or  TNP-modified  syngeneic  cells  (A),  or of different  amounts  of BGG  or  TNP- 
BGG  (B),  as  a  function  of effector:target  cell ratio.  (A): (O),  (A),  (D),  and  (•)  indicate  lysis 
of RDM-4-TNBS  targets  by  B10.BR  effectors  generated  by  addition  of 3  x  10  e,  1  x  10  e,  3  x 
I0  s,  and 1 × l0  s  BI0.BR-TNBS stimulators,  respectively.  Dashed line  indicates  the level  of 
lysis  generated by addition  of  unmodified syngeneic cells.  (0) and (A) indicate  lysis  of  EL- 
4-TNBS and RDM-4 targets,  respectively,  by effectors  generated by addition of 3 ×  10  s 
B10.BR-TNBS.  (B): (O), (A),  and (O) indicate lysis  of RDM-4-TNP  targets by B10.BR 
effectors  generated by addition of 100, 50, and 10 /~g/ml (final  culture  concentration) of 
TNP-BGG,  respectively.  Dashed line  indicates  the level  of  lysis  generated by addition of 
unmodified syngeneic cells.  (0) and (A) indicate  lysis  of  EL-4-TNBS and RDM-4 targets, 
respectively,  by effecters  generated by addition of  100 ~g/ml TNP-BGG. 
BGG  was  H-2 restricted  to the same extent as that resulting from sensitization 
with TNBS-modified syngeneic cells. 
Effect  of Antigen  Concentration  on  the  Generation  of Cytotoxic  Effector 
Cells.  The  phenomenon  observed  in  the  preceding  section  was  examined 
further by  comparing  the  number  of TNBS-modified syngeneic spleen  cells 
with the concentration of TNP-BGG required in the cultures for the generation 
of B10.BR  effector cells.  The  results  are  summarized  graphically  at  three 
effector:target cell ratios in Fig.  1.  Addition of 3  x  l0  s and  1  ×  l0  s B10.BR- 
TNBS cells  were  about  equally  effective in  generating  a  cytotoxic response 
(Fig. 1 A). Sensitization with 3  ×  10  s and 1 x  10  5 B10.BR-TNBS cells generated 356  TRINITROPHENYL  PROTEIN-INDUCED  H-2-RESTRICTED  EFFECTORS 
TABLE  II 
Mapping of the Restriction of  BI O.BR Effector Cells Generated by TNP-BGG to the K and D 
Regions of the H-2 Complex 
B10.BR Spleen  Percent specific lysis -+ standard  error detected on TNBS-modified targets indicated at effector:target  =  10:1 
cells sensitized 
by the addition  RDM-4*  RDM-4  B10.BR-  B10.A(4R)-  C3H.OH-  C57BL/10- 
of:  (kkkkkkkk)$  (kkkkkkkk)  LPS  LPS  LPS  LPS  A.TL-LPS  A.TH-LPS  A.AL-LPS 
(skkkkkkd)  (ssessesd)  (kkkkkkkd) 
(kkkkkkkk)  (kkbbbbbb)  (dddddddk)  (bbbbbbbb) 
BI0.BR  [6.8]  [19.5]  [14.7]  [14.1]  [1,5]  [i.i]  [0.4]  [2.6]  [4.4] 
BI0.BR-TNBS  -3,9 z  1.6  35.4 ± 4.1  22.9 -+ 4.9  33.0 -+ 4.7  12.5 -+ 2.5  3.7 ±  2,8  2.2 ±  2.3  3.8 ±  1.4  29.1 --.  2.6 
BGG  [1.3]  [8.9]  [5.3]  [6.2[  [-1.5]  [2.2]  [-4.2]  [0.5]  [-2.8] 
TNP-BGG  4.1  -  1.1  37.4 -+ 3.1  27.6 -+ 2.9  35.8 -+ 3.4  11.3 ±  1.3  6.5 ±  3.5  5.6 ±  L9  5.1 ±  1.3  23.3 x  5.7 
* This column of data was assayed  on unmodified  RDM-4 at effector:target =  20:1. 
Indicates the 1"1-2 haplotypes  at region and subregion  designations K, I-A, I-B, l-J, I-E, I-C, S, and D, respectively  (22). 
proportionally  weaker  responses.  The  cytotoxic  response  generated  by  the 
addition of TNP-BGG to the cultures was dependent upon the concentration of 
TNP-BGG at all concentrations  tested:  100  ~g/ml was more effective than  50 
~g/ml,  and 10 ~g/ml was ineffective (Fig.  1 B). 
Mapping of the Restriction of  Effector Cells Generated by TNP-BGG to the K 
and D Regions of the H-2 Complex.  Earlier  studies  indicated that  much of 
the H-2-restricted  cytotoxic activity  detected  on  TNBS-modified  target  cells 
was associated with products of the K  and D  regions of the murine MHC (7-9). 
To map the restriction of the effectors generated by TNP-BGG within the H-2 
complex,  cultures  of B10.BR spleen  cells  were  sensitized  by the  addition  of 
B10.BR-TNBS spleen cells or TNP-BGG.  The effectors generated  5 days later 
were assayed on  RDM-4-TNBS tumor cells,  as well as on  a  series of TNBS- 
modified,  cultured,  LPS-induced spleen blasts,  at effector:target cell ratios of 
20:1,  10:1, and 5:1. The results obtained using the 10:1 ratio are summarized in 
Table II. The lysis obtained by sensitization with either B10.BR-TNBS or TNP- 
BGG was detected on TNBS-modified LPS blast targets which expressed the k 
haplotype in K  and I-A regions [B10.A(4R)], in the D  region only (C3H.OH), or 
in any combination including K.  It should be noted that lysis on the C3H.OH 
target,  which  expressed  the  H-2D  k haplotype,  was  weaker  than  on  targets 
expressing the k haplotype in the K  region. Appreciable lysis was not detected 
on modified targets  which expressed the k  haplotype throughout  the I  region 
but not at K  or D  (A.TL).  No lysis was detected on unmodified  RDM-4  (left 
column of Table II) nor on any of the unmodified LPS blast targets  (data not 
shown). 
Generation  of H-2-Restricted  Cytotoxic  Effector  Cells  by Preincubation  of 
Spleen  Cells  with  TNP-Conjugated Proteins.  To  test whether  or not TNP- 
conjugated proteins could interact with cell surfaces in a  relatively short time 
period, spleen cells from B10.BR donors were incubated with BGG, TNP-BGG, 
BSA, or TNP-BSA for 1.5 or 3.0 h at 37°C in a CO2 incubator. The cells, washed 
two  or  three  times  in  BSS-FCS,  and  irradiated  with  2,000  R,  were used  as 
stimulators of B10.BR spleen cells during 5 days of culture. The lytic responses 
of the effectors generated  are shown in Fig.  2.  Appreciable cytotoxic activity 
was detected by using cells incubated with TNP-BGG for 1.5 h  (Fig.  2A) and 
for 3  h  (Fig.  2 B),  although  the  level of cytotoxicity was slightly lower than 
when  TNP-BGG  was  present  during  the  first  5  days  of culture  (Fig.  2 C). SCHMITT-VERHULST, PETTINELLI,  HENKART,  LUNNEY, 
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FIG.  2.  Effect of TNP protein preincubation time with stimulator cells on generation of 
effector cells.  (A,  B)  Lysis  of RDM-4-TNBS  targets  by  B10.BR  effectors generated  by 
addition of syngeneic spleen cells preincubated with 100 ~g/ml TNP-BGG (O) or 100 pg/ml 
BGG  (Q)  for 1.5  and  3.0  h,  respectively.  (C)  Lysis of RDM-4-TNBS  targets by  B10.BR 
effectors generated by addition of 100 pg/ml TNP-BGG (O), or 100/~g/ml BGG (O) to the 
5-day cultures, or by the addition of B10.BR-TNBS  modified (A) or B10.BR (A) stimulating 
cells to  the  5-day  cultures.  (D,  E)  Lysis  of RDM-4-TNBS  targets  by  B10.BR  effectors 
generated by addition of syngeneic spleen cells preincubated with 100/~g/ml BSA-TNP (O) 
or 100/~g/ml BSA (O) for 1.5 and 3.0 h, respectively. (F) Lysis of RDM-4-TNBS targets by 
B10.BR effectors generated by addition of 100 pg/ml TNP-BSA (O) or 100 pg/ml BSA (O) 
to the 5-day cultures. Standard errors of the mean are shown. 
Approximately equal levels of effector cell activity were detected when B10.BR 
spleen cells were incubated with TNP-BSA, whether the incubation period was 
for 1.5 or 3 h,  or whether TNP-BSA was present during the 5 days of culture 
(Fig. 2 D, E, F). Addition of TNP-BSA to the spleen cell cultures for 5 days was 
not more effective in generating  cytotoxic responses than were the 1.5- or 3-h 
preincubations.  Furthermore,  preincubation of spleen cells with TNP-BSA was 
more effective than with TNP-BGG, although  equivalent lytic responses were 
observed for the two TNP-conjugated proteins when they were present in the 
cultures during the 5 days of sensitization. 
Preincubation  of Target  Cells  with TNP-Conjugated  Proteins.  As  in  the 
above  experiments  where  TNP-conjugated  proteins  were  preincubated  with 
spleen cells for sensitization,  RDM-4 tumor cells were incubated with 100 ~g/ 
ml of BSA or TNP-BSA for 18 h  at 37°C in a  COs incubator and then washed. 
Those  RDM-4 cells  to be used as targets  were passed over a  Sephadex  G-10 
column before incubation  with BSA or TNP-BSA to remove phagocytic cells 
(6% latex-positive cells before column passage; 0.3% latex-positive after Sepha- 
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TABLE  HI 
Lysis of Target Cells Prepared by Preincubation With TNP-BSA by Effectors  Generated 
by Addition of TNP-Modified Syngeneic Cells or TNP-BSA 
Percent specific lysis ±  standard error assayed at effector:target cell ratio of 
40:1 
Cells fractionat~d over 
Unfractionated cells 
Sephadex G-10 columns* 
BI0.BR Spleen 
cells  sensi- 
tized by the 
addition of: 
RDM-  RDM- 
RDM-4-  RDM-  RDM- 
RDM-4  4(TNP-  4(TNP- 
TNBS  4(BSA)$  BSA)$  4(BSA)$  BSA)1: 
B10.BR  [7.7]  [31.0]  [11.7]  [9.7]  [6.2]  [11.3] 
B10.BR-TNBS  4.0  ±  2.1  38.0  ±  4.6  0.5  _+  1.8  18.8  ±  2.5  1.7  ±  1.9  29.4  ±  1.8 
BSA  [-1.5]  [17.6]  [4.4]  [3.2]  [0.7]  [5.9] 
TNP-BSA  9.5  ±  2.0  50.9  ±  4.4  8.1  -+ 2,4  27.6  ±  2.3  4.5  ±  1.3  33.0  ±  3.1 
* RDM-4 tumor targets fractionated over Sephadex G-10 columns before incubation with BSA or 
TNP-BSA. 
RDM-4 tumor targets incubated with BSA or TNP-BSA for 18 h at 37°C in CO2 incubator, and 
then washed before 5~Cr-labeling. 
for lysis  by B10.BR effector  cells  which had been generated by culturing  for 5 
days with unmodified or TNBS-modified syngeneic cells,  BSA, or BSA-TNP. 
The lysis  obtained on this  series  of  targets, as well as on unmodified RDM-4 
and TNBS-modified RDM-4, is  summarized in  Table HI. Effector  cells  generated 
by addition of B10.BR-TNBS,  or TNP-BSA  exhibited strong lysis  on TNBS- 
modified RDM-4 cells  or on RDM-4 cells  incubated with TNP-BSA, whether or 
not the  incubated  cells had  been  passed  over a  Sephadex  G-10 colmnn. 
Appreciable lysis  was not detected  on targets  incubated with BSA. 
Those RDM-4  tumor cells  to be used as targets were also incubated for 
shorter periods of  time (i.e.  10 or 150 rain)  with 100 /~g/rnl  TNP-BSA  before 
51Cr-labeling, and they were used as targets for effectors  which had been 
generated by addition of  B10.BR-TNBS  and TNP-BGG.  Portions of  these cell 
suspensions were stained with a rhodamine-conjugated anti-TNP antibody to 
determine whether or not TNP  groups could be detected on the RDM-4 cell 
surface  by fluorescence  microscopy (14).  The lysis  of  the target  cells  is  presented 
in  Table IV and the corresponding staining  of  the RDM-4 cells  is  shown in  Fig. 
3. Target cells  modified with 10 and 1 mM  TNBS  were lysed  equally at all 
three effector:target  ratios  by effectors  sensitized  with B10.BR-TNBS. Targets 
modified with 0.1 mM  TNBS  or preincubation with 100 ftg/rnl  TNP-BSA  for 
either 150 or 10 min were not lysed  as well as those modified at higher TNBS 
concentrations. Effectors generated  by addition of TNP-BGG  appeared  to 
exhibit weaker  lytic potential than those generated by sensitization with 
B10.BR-TNBS when assayed on modified targets  treated with 10 and 1.0 mM 
TNBS,  but not when  assayed on targets treated with 0.1 rnM TNBS  or 
preincubated with TNP-BSA for 150 or 10 rain. 
In this  experiment cytotoxicity  was detected  in  cultures  to which unmodified 
cells or proteins were added.  This phenomenon  of generation of cytotoxic 
effector cells in cultures not stimulated with modified cells  is consistently 
observed on TNP-rnodified,  H-2-matched tumor targets,  and is  proportional  to SCHMITT-VERHULST,  PETTINELLI,  HENKART,  LUNNEY,  AND  SHEARER  359 
TAnLE IV 
Lysis of H-2-Matched Target Cells Prepared by Incubation With TNBS or TNP-BSA by 
Effector Cells Generated by Addition  of TNBS-Modified Syngeneic Cells or TNP-BGG 
Spleen cells indi- 
cated were sensi- 
tized by the addi- 
tion of: 
BI0.BR: 
BIO.BR 
BI0.BR-TNBS 
BGG 
TNP-BGG 
B10.BR: 
B10.BR 
B10.BR-TNBS 
BGG 
TNP-BGG 
Percent specific  lysis ± standard error assayed on targets 
RDM-4-TNBS  i0 mM  (I0 rain)*  RDM-4-TNBS  1 mM  (i0 rain)  RDM-4-TNBS  0.1 mM  (10 rain)  RDM-4 
40:1  10:1  2.5:1 
[59.6]  [32.9]  [11.9] 
39.3 ±  1.7  51.3 -- 4.9  49.7 ±  2.6 
[63.3]  [35.1]  [16.2] 
22.9 ±  3.9  37.8 ±  5.4  20.6 ±  2.0 
RDM-4-(TNP.BSA) (150 rain} 
40:1  i0:i 
[38.5]  [14.7] 
48.2 ±  3.2  58.7 ±  3.2 
[43.1]  [14.7] 
33.7 ±  6.1  47.4 ±  3.2 
2.5:1 
[2.2] 
45.7 ±  4.5 
[3,3] 
29.7 ±  2.7 
RDM-4-(TNP-BSA)  I  I0 min) 
40:1  10:1  2.5:1  40:1  10:1  2.5:1 
[33.3]  [16.4]  [19.1]  [5.3]  [-2.7] 
40.2 ±  1.7  40,5 ±  3.4  40.6 ±  2.9  37.1 -+ 3.9  18.6 ±  1.9 
[37.4]  [20.7]  [8.3]  [23.5]  [1.O]  [1.3] 
34.1 -- 1.8  45.1 ±  4.1  25.8 ±  3.0  39.2 ±  2.8  46.3 ±  4.7  20.3 ±  2.2 
40:1  10:1 
[23.5]  [9.8] 
47.8 ±  1.9  47.4 ±  2.1 
[29.6]  [10.4] 
42.3 ±  2.8  53.2 ±  2.7 
2.5:1  40:1 
[-0.1]  [14.3] 
26.3 ±  1.7  -15.1  ±  1.5 
[1.9]  [22.3] 
23.3 ±  0.8  -15.6 ±  2.0 
RDM-4 (BSA) (150 
RDM-4 (BSA) (10 rain) 
rain) 
40:1  40:1 
[27.3]  [20.7] 
-16.8 ±  0.9  -11.8  ±  0.6 
[29.2]  [27.2] 
-14.4 ±  1.8  -15.5  ±  2,0 
* Indicates period of time (in minutes)  that target cells were  incubated with TNBS, TNP-BSA, or BSA. Target cells were washed three 
times after incubation in an excess of FBS-containing  media. 
the degree of reaction of the cells with TNBS.  Such autosensitization is not 
attributable to the addition of 100/zg BGG or BSA to the cultures, since spleen 
cells cultured alone exhibit the phenomenon. This accounts for the apparent 
decrease in lytic efficiency on the 10 mM TNBS-modified target cells as the 
effector:target ratio increased from 10:1 to 40:1. 
As shown in Fig.  3,  the staining of these RDM-4 targets with rhodamine- 
conjugated anti-TNP antibodies parallels in general the lysis of the targets 
modified with TNBS or incubated with TNP-BSA as described in the data of 
Table IV.  The staining of targets treated with 10 or 1.0 mM TNBS was bright 
(Fig.  3A)  (14). Staining of cells treated with 0.1  mM TNBS was faint, but 
visible and uniform (Fig. 3 B). Cells incubated with BSA for 150 min exhibited 
no detectable fluorescence (Fig.  3 C). Targets incubated with TNP-BSA for 150 
min (Fig. 3 D) stained with an intensity similar to that seen for 0.1 mM TNBS- 
treated  cells,  although  the  cells  incubated  with  TNP-BSA  exhibited  less 
uniform fluorescence  than did TNBS-treated cells. Faint but detectable fluores- 
cence was  observed with  the  targets  incubated for  10  min with TNP-BSA, 
showing a nonuniform patchy pattern of staining (Fig. 3 E). 
Role ofT Lymphocytes in H-2-Restricted Cytotoxic Responses to TNP-Conju- 
gated  Proteins.  To  determine whether or  not  the H-2-restricted cytotoxic 
effectors generated by addition of TNP-conjugated proteins are T lymphocytes, 
effector cells  were  incubated  with  rabbit  anti-mouse  brain  serum  and/or 
complement. The cells were then tested for their ability to lyse RDM-4-TNBS 
target cells (Table V). Treatment with the antiserum and complement  abolished 
the cytotoxic activity of effectors generated by sensitization with B10.BR-TNBS 
and greatly reduced the activity of effectors generated by addition of TNP- 
BGG.  No  effect was  detected by  treating  the  effectors with  antiserum  or 
complement alone. These results are consistent with the expression of the Thy- 
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Fro.  3.  ImmunofluorescentstainingofRDM-4tumortargetcellswithanti-TNPantibody. 
Tumor target cells were treated with TNBS or TNP-BSA as described in the text, washed, 
then stained with rhedamine-anti-TNP antibody at 0°C,  washed, and fixed with paraform- 
aldehyde.  Identical conditions of photographic exposure and processing were used for all 
samples. A. Cells modified with 1 mM TNBS, pH 7.4, 10 rain, 37°C.  B. Cells modified with 
0.1 mM TNBS, pH 7.4, 10 rain, 37°C.  C. Cells exposed to 100 ~g/ml BSA, 37°C,  150 rain. D. 
Cells exposed to 100/~g/ml TNP-BSA,  37°C,  150 rain. E.  Cells exposed to 100/~g/ml TNP- 
BSA, 37°C,  10 rain. 
TABLE  V 
Sensitivity of Effeetor  Cells Generated  by Addition of B10.BR-TNBS or TNP-BGG to 
Cultures of BIO.BR Spleen Cells to RAMB and Complement 
Percent specific lysis _+ standard error obtained using effector cells treated 
B10.BR Spleen  with:* 
cells sensitized by 
the addition of:  RAMB +  Corn- 
Nothing  Complement  RAMB 
plement 
B10. BR  [  16.6]  [20.7]  [  12.5]  [6.6] 
B10.BR-TNBS  23.8 -4- 2.1  22.4 _+ 3.1  21.0 -+ 1.4  -4.8  -  1.8 
BGG  [10.7]  [9.1]  [6.8]  [-0.6] 
TNP-BGG  30.9 ___ 1.1  30.5 -* 2.6  32.3 -+  1.6  7.7  -+ 1.8 
*  Effector:target cell ratio  =  10:1  on RDM-4-TNP  targets.  107 effector cells incubated with 1:20 
dilution of RAMB at room temperature for 30 min. Cells were then incubated with 1:5 dilution 
of complement at 37°C for 30 min. SCHMITT-VERHULST,  PETTINELLI,  HENKART,  LUNNEY,  AND  SHEARER 
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anti-H-2 ([]),  anti-TNP (O), anti-BSA (0) from lysates of radioiodinated BI0.A spleen 
cells  modified with 1 mM  TNBS  (A, B), or preincubated with 100/zg/ml of  TNP-BSA  for 2 
h at 37°C (C, D). 
B10.BR-TNBS or by addition of TNP-BGG. It is worth noting that the autosen- 
sitization  detected on RDM-4-TNBS targets  was also sensitive to RAMB and 
complement (see values in brackets). 
Comparison of the SDS-Gel Patterns of Anti-TNP, Anti-BSA and Anti-H-2 
Immunoprecipitates  of TNBS-Modified  Cells and  Cells  Preincubated  with 
TNP-BSA.  Experiments  were performed to compare the mode of binding of 
TNP groups on cells treated with TNBS (23, 24) and on cells preincubated with 
TNP-BSA under conditions for which those cells stimulate the generation of  H- 
2-restricted,  TNP-specific cytotoxicity. B10.A  spleen cellS treated  with  1 mM 
TNBS for 10  min  at 37°C,  or preincubated for 2 h  at 37°C  with  100  ~g/ml of 
TNP-BSA in culture medium were radioiodinated in the presence of lactoper- 
oxidase, solubilized in Nonidet P-40, and the cell lysates were immunoprecipi- 
tated  as  described  in  Materials  and  Methods.  The  SDS-gel  patterns  of the 
immunoprecipitates  obtained  with  normal  rabbit  serum  (NRS)  and  anti-H-2 
serum  (Fig.  4 C)  and  with  anti-TNP  and  anti-BSA  serum  (Fig.  4 D) for cells 362  TRINITROPHENYL  PROTEIN-INDUCED  H-2-RESTRICTED  EFFECTORS 
incubated with TNP-BSA indicate that the TNP groups are bound to a protein 
that has the same SDS-gel pattern as that precipitated with anti-BSA, and is 
distinct from the proteins precipitated with  anti-H-2.  The SDS-gel patterns 
obtained for proteins precipitated with NRS and anti-H-2  (Fig.  4 A) and anti- 
TNP and anti-BSA (Fig.  4 B) from cells reacted with 1 mM TNBS are shown 
for comparison. The general gel pattern for proteins immunoprecipitated with 
anti-TNP from the cells reacted with 1 mM TNBS is similar to that described 
by Forman et al. (24) in slightly different gel conditions. From their analysis of 
gel patterns after sequential immunoprecipitations with anti-TNP and anti-H- 
2  or anti-Ig,  these authors concluded that under their conditions, H-2-coded 
products as well as surface Ig were derivatized with TNP (23, 24). The results 
presented here suggest that the  TNP  groups  which can be  detected on the 
surface of spleen cells incubated for 2  h  with 100  /~g/ml of TNP-BSA are still 
bound to the carrier BSA and did not covalently modify//-2-coded proteins. 
Discussion 
Covalent modifications of lymphoid cell surfaces can lead to MHC-restricted 
cell-mediated lympholysis (6-10). In the present report, cytotoxic effector cells 
from B10.BR  mice were generated in the presence of soluble TNP-conjugated 
proteins. These effectors were capable of lysing TNBS-treated syngeneic target 
cells.  As in the case of cells sensitized with TNBS-treated cells, preferential 
lysis  was  detected on  TNBS-treated  tumor  targets,  H-2-matched with  the 
responding cells.  Intra-H-2  mapping of such restriction on LPS-stimulated, 
TNBS-modified blasts indicated that homology at:  (a) K  or K  plus I-A was as 
effective as at the entire H-2 complex; (b) the I  region was ineffective; and (c) 
the D region was much less effective than K or K plus I-A in detecting effectors 
generated by either TNBS-modified spleen cells (6,  7,  9, 25-27) or TNP-BGG. 
The observation that the response of B10.BR  spleen cells to TNP-BGG was 
much weaker when the effectors were assayed on TNBS-modified targets H-2- 
matched at D, than at K plus I-A is similar to the/r-controlled weak responses 
of lymphocytes from donors expressing the k haplotype at the K plus I  regions 
against TNBS-modified syngeneic cells (28). This similarity suggests that the 
same/r-controlled regulatory functions are involved whether the TNP group is 
covalently linked to  existing cell surface proteins or presented as  adsorbed 
protein (Discussion).  The generation of cytotoxic lymphocytes in the presence 
of TNP-conjugated soluble  proteins was  observed using spleen cells from a 
number of mouse strains of differing H-2 haplotypes and genetic backgrounds 
(B10.BR,  B10.A, C57BL/10, AKR/J,  BALB/c),  although  the  response  was 
highest in the H-2  k  strains tested (unpublished observations).  Furthermore, 
the  TNP-conjugated protein  which elicited  the  cytotoxic response  included 
TNP-ovalbumin and TNP-mouse serum albumin (unpublished observations). 
Effectors generated in culture by addition of TNP-BGG were sensitive to 
rabbit anti-mouse brain serum and complement, and are therefore probably T 
lymphocytes. Two possible mechanisms could account for the lysis generated 
by TNP-conjugated proteins: T-cell-mediated cytotoxicity; or antibody-depend- 
ent cellular cytotoxicity (ADCC). ADCC has been observed using spleen cells 
from mice immunized against DNP-conjugated proteins (29, 30). The observa- 
tion that the cytotoxicity generated in  vitro by addition of TNP-conjugated SCHMITT-VERHULST,  PETTINELLI,  HENKART,  LUNNEY,  AND  SHEARER  363 
proteins was not inhibited by TNP-lysine at the effector phase (unpublished 
results)  argues  against  this  cytotoxicity being ADCC-mediated  (30), and  is 
similar to that reported for effectors generated by TNBS-modified syngeneic 
cells (6). 
The observation that sensitization with TNP-conjugated proteins leads to the 
generation ofH-2-restricted effectors suggests that the TNP group (either with 
or  without  the  protein  carrier)  is  presented  on  the  cell  surface,  possibly 
presenting some groups in close proximity to H-2  gene products. Both spleen 
and  tumor cells  incubated for  10-150  min with TNP-BSA  were  fluorescent 
when incubated with rhodamine-labeled anti-TNP antibodies (shown for tumor 
cells in Fig. 3; results not shown for spleen cells). Tumor cells incubated with 
TNP-BSA served as functional targets for H-2-restricted effectors generated by 
addition of either TNBS-medified cells or TNP-BSA. Spleen cells preincubated 
for 30  min or more with TNP-BGG or TNP-BSA,  followed by washing and 
irradiation, served as stimulators of syngeneic responding cells for the genera- 
tion of H-2-restricted effectors. In contrast to sensitization with TNP-BSA, it 
should be noted that addition of BSA to cultures of spleen cells did not lead to 
the  generation of effectors detected on the  targets  preincubated with TNP- 
BSA. Since the TNP group appears not to be cleaved from the soluble protein 
carrier,  and  therefore  BSA  is  also  present  on  the  target  cells,  the  results 
presented here suggest that TNP-BSA exhibits greater cellular antigenicity 
than does unconjugated BSA. 
The mechanism by which the TNP-conjugated proteins  become associated 
with the cell  surface  remains to be elucidated.  A  few possibilities  can be 
considered.  The first  is  the possible  covalent  transfer  of  the TNP hapten from 
the  soluble  protein  carrier  to  a cell  surface  protein.  Although  arylation  reactions 
such  as  those  of  TNBS are  generally  irreversible,  Shaltiel  (31)  has  demonstrated 
that DNP  conjugates of cysteine,  tyrosine,  and histidine  (but  not of amino 
groups)  can be thiolized  by SH compounds such as cysteine.  Such a reaction,  if 
it occurs  with TNP, could potentially  result  in a protein-to-protein  transfer. 
However, since  TNBS reacts  only with  e- and a-amino groups and cysteine  SH 
groups in proteins (32,  33),  and since BSA and BGG  contain less  than one 
reactive  SH group per molecule, such a transfer  appears to be very unlikely. 
Analysis of  the SDS gel  patterns (Fig.  4)  of  anti-TNP, anti-BSA, and anti-H-2 
immunoprecipitates of  solubilized  1251-1abeled  surface  proteins  of  cells  preincu- 
bated for  2 h with TNP-BSA indicates  that  the TNP moiety was still  linked  to 
BSA, and therefore  was not covalently  transferred  to cell  surface  proteins. 
Another possible  mechanism by  which  soluble  TNP-conjugated proteins  could 
be associated with cell  surface components, including H-2-coded products, 
involves  the  processing  of  the TNP-protein  conjugates  by  macrophages. Incuba- 
tion of guinea pig macrophages with dinitrophenyl-conjugated guinea pig 
albumin for  brief  time  periods  has  been shown to  result  in  antigen presentation 
which induces proliferation  and lymphokine production by primed T-lympho- 
cytes (34).  The involvement of macrophages at least  at the target  cell  level 
cannot account for this phenomenon, since a Sephadex G-10 column-passed 
macrophage-depleted population of  tumor cells  served as good targets  for the 
H-2-restricted  lysis  ai~r incubation with TNP-BSA (Table  IV).  In contrast  to 
the incubation  experiments  with  target  cells,  it  is  not known whether antigenic 364  TRINITROPHENYL  PROTEIN-INDUCED  H-2-RESTRICTED  EFFECTORS 
processing occurs for these stimulators after the preincubation period during 
the 5 days of culture. 
A third possibility is that the TNP-conjugated soluble proteins nonspecifically 
interact with  cell  surfaces,  perhaps because of their  increased hydrophobic 
character. However, such an interaction would not be expected to generate an 
antigenic cell-bound complex that would be recognized by effecters sensitized 
against TNBS-modified syngeneic cells, since cells modified with TSD did not 
function  as  efficient targets  for  effectors generated in  the  TNBS-modifled 
cytotoxic system  (14). In fact,  it  is  difficult to  reconcile the  results  of the 
present report with a recent study in which murine lymphocytes  were modified 
with TSD, an amphipathic compound which modifies cell surfaces by noncova- 
lent linkage (14). TSD-treated cells did not stimulate the generation of effecter 
cells capable of lysing H-2-matched target cells modified with either TSD or 
TNBS  (14). Furthermore, TSD-modified cells did not serve as targets nor as 
blocking  cells  for  effectors generated by  sensitization  with  TNBS-modified 
syngeneic cells  (14). Such findings suggest that the random presentation of 
TNP groups on the cell surface, at a  density equal to or greater than that 
obtained with TNBS-medification, is not sufficient to provide an antigenic unit 
(composed of TNP and the relevant self components) that will function either 
at  the  sensitization  or  lytic  level.  If particular  MHC-coded structures  are 
required in close association with TNP, it is possible that TSD has placed the 
TNP  groups  in  an  unfavorable  position  with  respect  to  the  relevant  self 
components, whereas the random sticking of TNP-conjugated proteins to the 
cell surface provides some situations in which TNP is associated closely enough 
with the relevant H-2-coded  self structures to provide an antigenic unit. It is 
possible that TNP-proteins could be preferentially  bound to cell surface proteins 
(including H-2  products),  whereas TSD  might be  primarily bound the lipid 
bilayer. Another possibility is that the TNP group must be presented to the 
relevant lymphoid cells  on  an  appropriate  carrier,  and that  syngeneic cell 
surface determinants and proteins such as BSA and BGG are immunogenic 
carriers,  whereas stearyl-dextran is not.  This would imply that the  soluble 
proteins  are involved in  the recognition-a possibility which remains to be 
tested. 
The cytotexic results obtained with the TNP-conjugated proteins in which 
cross-reactivity was observed with TNBS-modified cells are also  difficult to 
reconcile with early published studies (10) in which the specificity of effectors 
generated by sensitization with syngeneic cells modified with TNBS did not 
lyse syngeneic  targets modified with N-(2,4,6-trinitrophenyl)-B-alanylglycylgly- 
cyl  (TNP-AGG)  acylazide.  At  least  two  possibilities  could  accunt  for  this 
apparent discrepancy. First,  it is possible  that the specificity associated with 
recognition of the  TNP  group is  dependent upon the  number of methylene 
carbons  in  the  adjacent  amino  acid.  The predominant group  reacting with 
TNBS on the cells and BSA would be the e-amino group of lysine. In contrast, 
in the TNP-AGG structure, TNP is linked to the B-amino group of B-alanine. 
This  might  also  account for the  lack  of cross-reactivity between TSD-  and 
TNBS-modified cells.  Alternatively,  it  is  possible  that  the  same  clones  of 
responding cells are activated by TNBS-modified syngeneic cells and the TNP- 
conjugated proteins, which are distinct from the clones triggered by TNP-AGG. SCHMITT-VERHULST, PETTINELLI,  HENKART,  LUNNEY,  AND  SHEARER  365 
In such a model, it would have to be assumed that the interaction of the TNBS 
and the TNP-conjugated protein with the relevant H-2-coded  structures are 
similar, but antigenically distinct from the interaction of TNP-AGG with such 
structures. The first of these possibilities could conform to a two-recepter model 
in which the TNP group plus the adjacent amino acid(s) would be recognized as 
a  distinct  entity  from  self H-2  products.  The  second  possibility  could  be 
consistent with  a  single receptor model involving the  antigen presented in 
association with H-2 products, but not necessarily involving covalent linkage 
to H-2-coded proteins. A  similar interpretation has been given for results in 
which UV-inactivated Sendal virus-treated cells served as H-2-restricted tar- 
gets  for  lysis  by  effecters  generated  by  sensitization  with  UV-inactivated 
Sendal virus-coated stimulater cells (13). 
It has been established in  a  series of earlier reports that cells covalently 
modified with TNBS can stimulate syngeneic mouse lymphocyte cultures to 
generate  H-2-restricted,  TNP-dependent  cytotexic  effecter  cells  (6-8).  The 
results  presented  in  this  report broaden the  limits of the  experiments and 
interpretations imposed by covalent modification with TNBS to include TNP 
groups attached to soluble protein carriers. Thus, the chemically modified, H- 
2-restricted cytotoxicity model may not depend on actual covalent conjugation 
of the TNP group to H-2-coded cell surface products, and therefore could be 
similar to the H-2-restricted viral and weak transplantation antigen models 
(1-5, 11-13). These findings could also indicate the possible role of  H-2-restricted 
cytotoxic reactions involving autoimmunity generated by soluble components 
associated with autologous cells. 
Summary 
Murine spleen cells from normal donors were cultured in vitro with trinitro- 
benzene  sulfonate  (TNBS)-conjugated  soluble  proteins,  i.e.,  bovine  gamma 
globulin (TNP-BGG) or bovine serum albumin (TNP-BSA). Addition of 100 ~g 
of any of these TNP-proteins to the spleen cell cultures led to the generation of 
cytotoxic T-cell effectors which were H-2-restricted and TNP-specific. The lytic 
potential of such effectors was comparable to that generated by sensitization 
with TNBS-modified syngeneic cells, and was restricted to haplotypes shared 
at the K  or K  plus I-A, or the D  regions of the H-2 complex. Greater effecter 
cell activity was generated by addition of TNP-BGG against TNBS-modified 
targets which shared K  plus I-A  than against modified targets which shared 
the D  region with the responding cells, which suggests that the same immune 
response genes are involved when the response is generated by the addition of 
TNP-conjugated soluble proteins or of TNBS-modified cells. 
H-2-restricted, TNP-specific effecter cells were generated by culturing mouse 
spleen cells with syngeneic cells which had been preincubated with TNP-BGG 
or TNP-BSA for 1.5  h.  The addition of unconjugated soluble proteins to the 
cultures did not result in cytotoxic effectors detectable on H-2-matched targets, 
whether the targets were prepared by modification with TNBS, or by incubation 
with either the unconjugated or TNP-conjugated proteins. Depletion of phago- 
cytic cells in the tumor preparation by Sephadex G-10 column fractionation 
before incubation with TNP-BSA had no effect on their lysis by the relevant 
effector cells. Immunofluorescent staining of tumor target cells with anti-TNP 366  TRINITROPHENYL  PROTEIN-INDUCED  H-2-RESTRICTED  EFFECTORS 
antibodies indicated that TNP could be detected on the tumor cells within 10 
rain of incubation with TNP-BSA. The cytotoxic response generated by addition 
of the TNP-proteins to spleen cell cultures was found to be T-cell dependent at 
the effector phase,  as shown by the sensitivity of the lytic phase to absorbed 
RAMB  and  complement.  Furthermore,  the  response  did  not  appear  to  be 
attributable to antibody-dependent cellular cytotoxicity. 
Three mechanisms were considered which could account for the generation 
of H-2-restricted,  TNP-specific,  cytotoxic T-cell  effectors by  the  addition  of 
soluble TNP-proteins. These include covalent linkage of activated TNP groups 
from the soluble proteins to cell surface components, macrophage processing of 
the  soluble  conjugates  and  presentation  to  the  responding  lymphocytes in 
association with H-2-coded self structures,  or  hydrophobic interaction of the 
TNP-proteins to cell surfaces. Results obtained from sodium dodecyl sulfate gel 
patterns  indicating that  cell-bound  TNP  was  still  linked  to  BSA,  and  the 
observation that phagocytic-depleted cells could interact with the soluble TNP- 
proteins and function as H-2-restricted targets,  appear not to favor the first 
two proposed mechanisms. 
The authors are  grateful to Cindy Neels, Pamela Gilheany, and Matthew Miller for their 
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Schoenfelder for her preparation of the manuscript. 
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